We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$812M
AUM Growth
+$5.96M
Cap. Flow
-$26.9M
Cap. Flow %
-3.32%
Top 10 Hldgs %
32.2%
Holding
92
New
3
Increased
34
Reduced
31
Closed
7

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$13.4M
2
TDW icon
Tidewater
TDW
+$9.77M
3
MAT icon
Mattel
MAT
+$9.66M
4
CAG icon
Conagra Brands
CAG
+$6.65M
5
STT icon
State Street
STT
+$5.81M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Technology 16.93%
3 Financials 15.18%
4 Energy 10.88%
5 Consumer Staples 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDW icon
26
Tidewater
TDW
$3.71B
$13.2M 1.62%
8,406
+5,976
+246% +$9.77M
NSC icon
27
Norfolk Southern
NSC
$76.1B
$12.7M 1.57%
130,715
-5,747
-4% -$533K
MRK icon
28
Merck
MRK
$326B
$12.7M 1.56%
234,167
-56,956
-20% -$2.95M
TDC icon
29
Teradata
TDC
$2.75B
$12.1M 1.49%
246,295
+88,295
+56% +$3.98M
PPL
30
PPL Corp
PPL
$27.3B
$11.7M 1.44%
378,918
-242,033
-39% -$7.03M
VIV icon
31
Telefônica Brasil
VIV
$21B
$10.7M 1.32%
503,696
+76,360
+18% +$1.47M
TPR icon
32
Tapestry
TPR
$30.5B
$10.5M 1.3%
211,681
+49,663
+31% +$2.47M
COP icon
33
ConocoPhillips
COP
$139B
$10.4M 1.28%
147,668
+866
+0.6% +$58K
ANF icon
34
Abercrombie & Fitch
ANF
$4.58B
$10.3M 1.26%
266,448
-63,236
-19% -$2.31M
DOX icon
35
Amdocs
DOX
$5.83B
$9.99M 1.23%
214,980
-41,697
-16% -$1.82M
CSX icon
36
CSX Corp
CSX
$94.2B
$9.96M 1.23%
1,030,929
-76,278
-7% -$707K
MAT icon
37
Mattel
MAT
$4.49B
$9.76M 1.2%
+243,272
New +$9.66M
SWK icon
38
Stanley Black & Decker
SWK
$14.6B
$9.44M 1.16%
116,150
+30,720
+36% +$2.46M
DD
39
DELISTED
Du Pont De Nemours E I
DD
$9.19M 1.13%
144,279
-304
-0.2% -$18.6K
HWC icon
40
Hancock Whitney
HWC
$6.19B
$8.99M 1.11%
245,233
+14,372
+6% +$511K
CAH icon
41
Cardinal Health
CAH
$54.5B
$8.85M 1.09%
126,392
-37,298
-23% -$2.59M
DVN icon
42
Devon Energy
DVN
$49.2B
$8.79M 1.08%
131,370
+5,556
+4% +$345K
F icon
43
Ford
F
$59.6B
$8.76M 1.08%
561,399
+150,719
+37% +$2.33M
ORCL icon
44
Oracle
ORCL
$346B
$8.28M 1.02%
202,328
-9,946
-5% -$379K
TAP icon
45
Molson Coors Class B
TAP
$7.97B
$7.54M 0.93%
128,061
-27,442
-18% -$1.53M
IBN icon
46
ICICI Bank
IBN
$109B
$7.51M 0.93%
942,673
+209,198
+29% +$1.4M
PTR
47
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$6.16M 0.76%
56,794
+2,843
+5% +$291K
SNY icon
48
Sanofi
SNY
$109B
$5.17M 0.64%
98,963
+6,195
+7% +$314K
MTB icon
49
M&T Bank
MTB
$36.6B
$4.59M 0.57%
37,834
-5,797
-13% -$669K
FNB icon
50
FNB Corp
FNB
$6.81B
$4.52M 0.56%
337,092
-53,008
-14% -$661K

Similar funds

Foyston, Gordon, & Payne's Q1 2014 Portfolio in Review

As of Q1 2014, Foyston, Gordon, & Payne held 92 positions worth $812M, up 0.74% from $806M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $26.9M in Q1 2014, closing 7 positions and reducing 31 holdings. Its most notable exit was Newell Brands, an estimated $8.15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in iShares Russell 2000 ETF worth $13.5M.

  • Foyston, Gordon, & Payne's largest Q1 2014 buy was iShares Russell 2000 ETF: 116,200 shares worth $13.5M.
  • Foyston, Gordon, & Payne added most to Tidewater in Q1 2014, an estimated $9.77M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $22M.
  • Foyston, Gordon, & Payne fully exited Newell Brands in Q1 2014, selling an estimated $8.15M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 32% of its $812M portfolio in Q1 2014.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 7 in Q1 2014.
  • Foyston, Gordon, & Payne's portfolio value rose 0.74% quarter-over-quarter to $812M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2014, filed 14 May 2014.